‘±EΥ°± γςiJpκW |
→ pκWCfbNX |
y s z |
t1/2 ihalf-life periodj ΌΈϊ |
TDC iTailored Dose Chemotherapyj ―Εεp±Β\ΚiMRDj |
TDM iTherapeutic drug monitoringj ‘±ς¨j^O |
TLO iTechnology Licensing Organizationj ZpΪ]@Φ |
Tmax imaximum drug concentration timej ΕZxBΤ |
ίι^Wv |
→ pκWCfbNX |